Status:
COMPLETED
Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Colon Cancer
Eligibility:
All Genders
45-75 years
Brief Summary
The study is a cross-sectional survey study targeting patients aged 45-75 who had their screening or surveillance colonoscopy postponed or delayed due to the COVID pandemic. Study staff will survey a ...
Detailed Description
The study is a cross-sectional survey study targeting patients aged 45-75 who had their screening or surveillance colonoscopy postponed or delayed due to the COVID pandemic. Staff will survey a random...
Eligibility Criteria
Inclusion
- Adults, age 45-75
- Had screening or surveillance colonoscopy delayed due to COVID-19
- Either first screening colonoscopy or a routine screening or surveillance colonoscopy for low to moderate risk patients (as indicated by 3-10 year recommended follow up frequency from prior test)
Exclusion
- Diagnostic colonoscopy
- High risk for colorectal cancer as indicated by 1 year follow up schedule
- Prior history of colon cancer or irritable bowel syndrome
- Unable to read or write in English or Spanish
Key Trial Info
Start Date :
June 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT04432870
Start Date
June 9 2020
End Date
June 30 2021
Last Update
September 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114